Osteoarthritis Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Osteoarthritis Market?
The osteoarthritis market has seen strong growth in recent years. It will grow from $6.87 billion in 2024 to $7.53 billion in 2025, at a CAGR of 9.6%. This growth is attributed to the aging population, the obesity epidemic, advancements in imaging techniques, and pain management solutions.

The osteoarthritis market is projected to experience strong growth, reaching $10.64 billion by 2029 at a CAGR of 9.0%. This growth is attributed to the rising adoption of non-pharmacological approaches, disease-modifying osteoarthritis drugs (DMOADs), personalized medicine, and telehealth and remote monitoring. Trends in this market include regenerative therapies, wearable devices, AI in diagnosis, and digital health tools.

What Factors Are Propelling the Expansion of the Osteoarthritis Market?
The increasing prevalence of obesity-related disorders is expected to drive the osteoarthritis market in the years ahead. Obesity-related disorders encompass various health conditions arising from excessive body fat, often linked to factors such as high-calorie diets, processed food consumption, and lack of physical activity. Obesity can contribute to osteoarthritis by placing additional strain on joints, triggering inflammation, and affecting hormone regulation, thereby increasing joint wear and tear. For instance, the World Obesity Atlas 2022, published by the World Obesity Federation, a UK-based nonprofit organization, estimated that 1 billion people-comprising 1 in 7 men and 1 in 5 women-will be living with obesity by 2030. Additionally, projections indicate that by 2035, 4 billion individuals, or 51% of the global population, will be classified as overweight or obese. Consequently, the rise in obesity-related disorders is fueling the growth of the osteoarthritis market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

Which Businesses Are at the Forefront of Osteoarthritis Market Development?
Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

What Are the Latest Innovations in the Osteoarthritis Market?
Leading companies in the osteoarthritis market are adopting strategic partnerships to advance technology integration and expand their market presence. Strategic partnerships involve collaborative efforts between organizations that pool resources and expertise to achieve shared goals. For example, in July 2024, LG Chem, a South Korea-based pharmaceutical company, partnered with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and production firm, to introduce Synovian injection for osteoarthritis treatment in China. Synovian provides similar therapeutic benefits to multi-injection treatments but requires only a single administration. Its key feature includes high-molecular-weight (10 million Dalton) hyaluronic acid, which enhances joint function and viscoelasticity while significantly alleviating knee pain based on clinical phase 3 trials.

How Is the Osteoarthritis Market Segmented?
The osteoarthritis market covered in this report is segmented -

1) By Treatment: Medication, Surgery, Therapy
2) By Diagnosis: Imaging, Joint Fluid Analysis
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Medical Institutes

Subsegments:
1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)
2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion
3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Where Is the Osteoarthritis Market Growth Most Prominent?
North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Osteoarthritis Global Market Report?

- Market Size Analysis: Analyze the Osteoarthritis Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Osteoarthritis Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Osteoarthritis Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Osteoarthritis Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.